ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

0ACX Centessa Pharmaceuticals Plc

0.00
0.00 (0.00%)

Centessa Pharmaceuticals Financial Summary

The current 0ACX market cap is 0. The company's latest EPS is USD and P/E is N/A.

Year End 31 December 2022 20212022
USD (US$)USD (US$)
Total Revenue 00
Operating Income -374.08M-212.26M
Net Income -381.07M-216.21M
Year End 31 December 2022 20212022
USD (US$)USD (US$)
Total Assets 629.64M444.31M
Total Liabilities 138.08M108.14M
Total Equity 491.55M336.17M

Cash Flow

Year End 31 December 2022 20212022
USD (US$)USD (US$)
Operating -135.11M-200.55M
Investing 63.26M-931k
Financing 660.15M457k
Market Cap 0
Price to Earnings Ratio N/A
Price to Sales Ratio 0
Price to Cash Ratio 0
Price to Book Ratio 0
Dividend Yield -

Share Statistics

Shares Outstanding 0
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0 (0%)

Company Info

Company Name Centessa Pharmaceuticals Plc
Address 3rd floor
cheshire WA14 2DT
Website https://www.centessa.com
Industry coml physical, biologcl resh (8731)

Your Recent History